![]() UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | ||
Founding Date | Founding Date 1915 | Founding Date 1928 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations København, DK HQ Buenos Aires, AR North Ryde, AU Wien, AT Bruxelles, BE Rio De Janeiro, BR Sofia, BG see more | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 5,700 | Employees 9,052 |
Valuation ($) | Valuation ($) 6.2 b | Valuation ($) 34.3 b |
Financial | ||
Revenue (est.) | Revenue (est.) kr24.6b (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods kr2.7b (FY, 2025) | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit kr22b (FY, 2025) | Gross profit €7.2b (FY, 2025) |
Net income | Net income kr3.2b (FY, 2025) | Net income €1.6b (FY, 2025) |
Operating ⚠ | ||
Countries | Countries 100 (May, 2024) | Countries 35 (FY, 2019) |

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company